The trademark application Nitroxolin forte was filed by MIP Pharma GmbH, a corporation established under the laws of the Federal Republic of Germany (the "Applicant"). Application refused.
The application was filed in German (English was selected as the second language).
The Refusal with reference B 018752357 was Rejected according to Article 7(1)(b) EUTMR with decision issued on December 11, 2022 by the EUIPO.